Literature DB >> 6156995

Glycoproteins with type common and type specific antigenic sites excreted from cells infected with herpes simplex virus types 1 and 2.

R E Randall, R A Killington, D H Watson.   

Abstract

Agar immunodiffusion tests demonstrated that BHK 21 cells infected with either HSV I or HSV 2 release only a few HSV-specified antigens into the extracellular fluid (infected cell released polypeptides-ICRP). Neutralization blocking experiments showed that the majority of antigens/(including the Band II common antigen) involved as target sites in antibody-mediated virus neutralization are present in the ICRP of both HSV I and HSV 2.SDS-PAGE identified six regions of virus-specified proteins in the ICRP from both HSV I- and HSV 2-infected BHK cells. All these specifically released proteins are glycosylated, although to varying degrees. The SDS-PAGE profiles of HSV I and HSV 2 ICRP are different but do show some similarities, the most notable being a highly glycosylated protein with an estimated mol. wt. of 50,000 to 54,000 in HSV I ICRP and 52,000 to 56,000 in HSV 2 ICRP. Immune precipitation demonstrated that these two proteins contain the Band II antigenic site. Similar studies showed that the major type I specific antigenic site, which is involved as a target site in the neutralization of virus infectivity, is located in the highest mol. wt. glycoprotein region of HSV I ICRP and has a similar mobility to the VP7/8 region of purified enveloped virus.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156995     DOI: 10.1099/0022-1317-48-2-297

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Characterization of herpesvirus sylvilagus glycoproteins released into the culture medium of infected cells: antisera to gp13 and gp32 neutralize viral infectivity in vitro and identify antigens on plasma membranes of infected cells.

Authors:  A K Patick; H C Hinze
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides.

Authors:  J W Bastardo; J L McKimm-Breschkin; S Sonza; L D Mercer; I H Holmes
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

3.  Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.

Authors:  H S Marsden; A Buckmaster; J W Palfreyman; R G Hope; A C Minson
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

4.  Viral-bacterial pneumonia in calves: duration of the interaction between bovine herpesvirus 1 and Pasteurella haemolytica.

Authors:  W D Yates; L A Babiuk; K W Jericho
Journal:  Can J Comp Med       Date:  1983-07

5.  Mapping and sequence of the gene for the pseudorabies virus glycoprotein which accumulates in the medium of infected cells.

Authors:  T J Rea; J G Timmins; G W Long; L E Post
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

6.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

7.  Delayed hypersensitivity to herpes simplex virus: murine model.

Authors:  R D Schrier; L I Pizer; J W Moorhead
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

8.  Crossed immunoelectrophoretic analysis of herpes simplex virus type 2 proteins. Characterization of antigen-5.

Authors:  B Norrild; A B Andersen; R Feldborg
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.